News Channels

19 Nov 2020 European Commission approves Supemtek (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older
19 Nov 2020 Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
19 Nov 2020 Bio-Path Holdings Announces First Patient Dosed in Phase 1 Clinical Trial of BP1002
19 Nov 2020 Durable Responses with ADP-A2M4 in Synovial Sarcoma with Confirmed Responses in 44% of Patients and Disease Control Rate of 94% Presented at CTOS
19 Nov 2020 PIONYR Immunotherapeutics Initiates Phase 1 Clinical Study Of PY314
19 Nov 2020 Acurx Announces Positive Phase 2A Clinical Trial Results for Ibezapolstat in C. difficile Infection at Prominent International Conference
19 Nov 2020 VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection
19 Nov 2020 Omeros Submits its Biologics License Application to U.S. FDA for Narsoplimab in HSCT-TMA
19 Nov 2020 Adagio Therapeutics COVID-19 Antibody Demonstrates Best-in-Class Breadth and Potency Against a Range of Coronaviruses that Pose Human Threat
19 Nov 2020 NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline
19 Nov 2020 Alnylam Receives Approval for OXLUMO™ (lumasiran) in the European Union for the Treatment of Primary Hyperoxaluria Type 1 in All Age Groups
19 Nov 2020 VBI Vaccines Announces Positive Interim Phase 2a Data from VBI-1901 in Recurrent GBM
19 Nov 2020 Bristol secures £45M to advance gene therapy treatment of chronic kidney diseases
19 Nov 2020 Genoscience Pharma completes successful phase 1b trial evaluating GNS561, PPT-1 inhibitor, in patients with primary and secondary liver cancer
19 Nov 2020 Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV
19 Nov 2020 ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
19 Nov 2020 Milestone Pharmaceuticals Announces First Patient Enrolled in RAPID, a Pivotal Phase 3 Study of Etripamil in PSVT
19 Nov 2020 Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
18 Nov 2020 Samsung Bioepis and Biogen Announce FDA Filing Acceptance of SB11, A Proposed Biosimilar Referencing Lucentis® (ranibizumab)
18 Nov 2020 Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up